The 16-hospital system credited some of this loss to the $3.1 million pre-opening and startup costs related to a new hospital campus and an additional loss attributed to $5.9 million in legal settlements and other non-recurring costs. These costs were partially offset by $1.4 million in net earnings from continuing operations.
They system’s total revenue in the third quarter of FY 2015 topped $686 million, up 8.5 percent from revenues of about $633 million in the same period of last year. Adjusted EBITDA for the third quarter increased 25.2 percent over the same period last year to $63 million from $50.3 million.
For the nine months ended June 30, IASIS posted a $1.7 million net loss, which is improved for the same period last year, when the company recorded a $20.8 million net loss. Revenues year-to-date also continue to improve over last year, showing a 10.6 percent increase over last year to $2.5 billion from $1.9 billion the year prior. Year-to-date the company has recorded $3.7 million in pre-opening and startup losses for its new hospital campus, as well as $8.5 million in legal settlement and other fees.
More articles on finance:
Medicare’s voluntary bundled payment program grows by 2,100 participants
5 hospital CFOs in the headlines
11 recent hospital outlook and rating actions
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
